Search
for
Sort by
Research 181–210 of 1000+
- A rare cause of postmenopausal hyperandrogenism
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Chapter 23. Therapeutic Control of Androgen Action
- Androgen Receptor Ligands: Agonists and Antagonists
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Transsexualism
- Androgens and Antiandrogens
- Kaposi Varicelliform Eruption in a Patient with Pemphigus Vulgaris: A Case Report and Review of the Literature
- Physiology of Testicular Function
- Canine Sertoli cell tumor: anti-Müllerian hormone, inhibin B, and estrone sulphate
- P23 A case of visceral leishmaniasis presenting as seropositive erosive rheumatoid arthritis in an immunocompromised patient
- Case Report: Disorder of Sexual Development in a Chinese Crested Dog With XX/XY Leukocyte Chimerism and Mixed Cell Testicular Tumors
- Hair cortisol in polycystic ovary syndrome
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- Report on the 11th National Congress AICPE (Associazione Italiana di Chirurgia Plastica Estetica) Held in Rimini, Italy, 12–14 April 2024
- Testosterone therapy for transgender men
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Endocrine Influences on Hair Growth
- Analysis of androgen receptor expression and activity in the mouse brain
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors
- Soft Nails After Treatment With Aromatic Retinoids
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Recommendations of endocrine treatment for patients with gender dysphoria